Literature DB >> 30206408

Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Huanwen Wu1, Marilyn M Bui2, Lian Zhou3, Dongmei Li1, Hui Zhang1, Dingrong Zhong4.   

Abstract

Information on the heterogeneity of phosphaturic mesenchymal tumor, a rare entity associated with tumor-induced osteomalacia, is limited. In this retrospective analysis of 222 phosphaturic mesenchymal tumors, 22 cases exhibited mixed mesenchymal and epithelial elements, which we propose to term "phosphaturic mesenchymal tumor, mixed epithelial, and connective tissue type." Phosphaturic mesenchymal tumor of the mixed epithelial and connective tissue type showed a distinctive and significant male predominance (male:female = 2.67:1), with most patients diagnosed at <40 years old. Moreover, all tumors were mainly located in the alveolar bone with focal invasion into surrounding soft tissue and oral mucosa, which could be detected preoperatively by oral examination. The mesenchymal component, composed of spindled cells resembling fibroblasts or myofibroblasts arranged in a storiform or fascicular pattern, exhibited a less prominent vasculature and lower cellularity than the typical phosphaturic mesenchymal tumor (mixed connective tissue type). The epithelial component was typically haphazardly and diffusely distributed throughout the tumor, forming small, irregular nests resembling odontogenic epithelial nests. All cases were immunoreactive for fibroblast growth factor-23, somatostatin receptor 2A, and NSE in both components. Mostly also demonstrated positive staining for CD99 (21/22, 96%), CD56 (16/22, 73%), Bcl-2 (21/22, 96%), and D2-40 (19/22, 86%) in one or both components. S100 was positive in both components in one of seven cases. Interestingly, immunoreactivity was typically stronger and more diffuse in the epithelial than in the paired mesenchymal components. The mesenchymal component was also diffusely positive for CD68 (17/17, 100%) and showed variable focal staining for SMA (15/22, 68%) and CD34 (9/19, 47 %). These results indicate that phosphaturic mesenchymal tumor of the mixed epithelial and connective tissue type has distinctive clinicopathological characteristics and a polyimmunophenotypic profile.

Entities:  

Mesh:

Year:  2018        PMID: 30206408     DOI: 10.1038/s41379-018-0100-0

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  73 in total

1.  Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years.

Authors:  R A McCANCE
Journal:  Q J Med       Date:  1947-01

2.  "Tertiary" hyperparathyroidism and apparent "cure" of vitamin-D-resistant rickets after removal of an ossifying mesenchymal tumor of the pharynx.

Authors:  J Olefsky; R Kempson; H Jones; G Reaven
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

3.  Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.

Authors:  Yoshiyuki Mori; Toru Ogasawara; Toru Motoi; Yuichiro Shimizu; Daichi Chikazu; Kazumi Tamura; Seiji Fukumoto; Tsuyoshi Takato
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03

4.  [Osteomalacia of mesenchymatous tumors. Apropos of a new case].

Authors:  E Lejeune; M Bouvier; P Meunier; J L Vauzelle; J P Deplante; L David; G Llorca; E André-Fouet
Journal:  Rev Rhum Mal Osteoartic       Date:  1979-03

5.  Neoplastic pathology of oncogenic osteomalacia/rickets.

Authors:  N Weidner; R S Bar; D Weiss; M P Strottmann
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

6.  Hypophosphaturic mesenchymal tumor of the ethmoid associated with oncogenic osteomalacia.

Authors:  Claudio Ungari; Giovanni Rocchi; Claudio Rinna; Alessandro Agrillo; Alessandro Lattanzi; Mario Pagnoni
Journal:  J Craniofac Surg       Date:  2004-05       Impact factor: 1.046

7.  Vitamin D metabolite levels in oncogenic osteomalacia.

Authors:  R A Sweet; J L Males; A J Hamstra; H F DeLuca
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

8.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets.

Authors:  N Weidner; D Santa Cruz
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

9.  Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series.

Authors:  Hanadi A Fatani; Mohamad Sunbuli; Stephen Y Lai; Diana Bell
Journal:  Ann Diagn Pathol       Date:  2012-09-13       Impact factor: 2.090

10.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

View more
  10 in total

Review 1.  Tumor-Induced Osteomalacia.

Authors:  Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins
Journal:  Calcif Tissue Int       Date:  2020-06-05       Impact factor: 4.333

2.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

Review 3.  Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region.

Authors:  Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Head Neck Pathol       Date:  2020-01-16

4.  Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature.

Authors:  Teik Hin Tan; Ew-Jun Chen; Ming Tsuey Chew; Ping Ching Chye; Ming Wong
Journal:  Nucl Med Mol Imaging       Date:  2021-04-19

5.  Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.

Authors:  Xiang Li; Yan Jiang; Li Huo; Huanwen Wu; Yong Liu; Jin Jin; Wei Yu; Wei Lv; Lian Zhou; Yu Xia; Ou Wang; Mei Li; Xiaoping Xing; Yue Chi; Ruizhi Jiajue; Lijia Cui; Xunwu Meng; Weibo Xia
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

Review 6.  Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway.

Authors:  Mohsin A M Hussein; Francesco Pio Cafarelli; Maria Teresa Paparella; Winston J Rennie; Giuseppe Guglielmi
Journal:  Radiol Med       Date:  2021-08-28       Impact factor: 3.469

7.  Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.

Authors:  Luisella Cianferotti; Chiara Delli Poggi; Francesco Bertoldo; Carla Caffarelli; Chiara Crotti; Davide Gatti; Sandro Giannini; Stefano Gonnelli; Maurizio Mazzantini; Viapiana Ombretta; Stefania Sella; Angela Setti; Massimo Varenna; Francesca Zucchi; Maria Luisa Brandi
Journal:  Endocrine       Date:  2022-04-05       Impact factor: 3.925

Review 8.  Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.

Authors:  Deepika Mishra; Harpreet Kaur; Ashu Seith Bhalla; Smita Manchanda; Jithin Sasikumar; Bhaskar Agarwal; Ajoy Roychoudhury
Journal:  Head Neck Pathol       Date:  2021-01-04

9.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

10.  Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors.

Authors:  Dongmei Li; Ran Zhu; Lian Zhou; Dingrong Zhong
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.